WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Determination That REVIA (Naltrexone Hydrochloride) Tablets, 50 Milligrams Was Not Withdrawn From Sale for Reasons of S... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; MRESVIA (Respiratory Syncy... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products;... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; UNLOXCYT. The notice was published in the ... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Notice of Approval of Product Under Priority Review Voucher; Material Threat Medical Countermeasure Priority Review Vou... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Determination That CHEWTADZY (Tadalafil) Chewable Tablets, 5 Milligrams, 10 Milligrams, 20 Milligrams, Were Not Withdra... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of Prescription Drugs. The... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs. The notice was published... Read More
WASHINGTON, April 16 -- Food and Drug Administration has issued a notice called: Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; AREXVY (Respiratory Syncyt... Read More